C12N 2710/22032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/22032 (Use of virus as therapeutic agent, other than vaccine) appears on 4 US grants and 12 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 12
- Assignees
- 3
- Inventors
- 12
- Latest grant
- 22 Mar 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 3 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 2 |
By publication year.
Recent patents
- Drug delivery system and methods providing thereof22 Mar 2022US 11,279,938 B2NEUWAY Pharma GmbH
- Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders28 Jan 2014US 8,637,447 B2Gene Vector Technologies (GVT)
- Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders17 Apr 2012US 8,158,576 B2G.V.T. - Gene Vector Technologies Ltd.
- Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders28 Sep 2010US 7,803,761 B2Gene Vector Technologies (GVT)
- A method for providing a vlp derived from john cunningham virus25 May 2023US 2023/0157972 A1NEUWAY Pharma GmbH
- Vlp for the treatment of a lysosomal storage disease25 May 2023US 2023/0159938 A1NEUWAY Pharma GmbH
- A novel drug delivery system and methods providing thereof30 Sep 2021US 2021/0301302 A1NEUWAY Pharma GmbH
- Vlp for the treatment of a lysosomal storage disease16 Jul 2020US 2020/0224205 A1NEUWAY Pharma GmbH
- Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders11 Nov 2010US 2010/0284974 A1Gene Vector Technologies (GVT)
Most cited
By later US patents